Pesquisar
Mediwound Ltd
MDWDAdicionar à lista de desejos
15.160USD
+0.340+2.29%
Fechamento 07/02, 13:00（ET）Cotações atrasadas em 15 min
194.84MValor de mercado
PerdaP/L TTM
Mais detalhes de Mediwound Ltd Empresa
Mediwound Ltd is an Israel-based biopharmaceutical company that develops, manufactures and commercializes novel, cost effective, bio-therapeutic solutions for tissue repair and regeneration. Company's portfolio is focused on next-generation protein-based therapies for burn and wound care and tissue repair and includes products such as, NexoBrid, a concentrate of proteolytic enzymes enriched in bromelain, which is an easy to use, topically-applied product that removes eschar in four hours without harming the surrounding healthy tissues.; EscharEx biological drug candidate for the debridement of chronic and other hard-to-heal wounds; MW005 a topically applied biological drug candidate for the treatment of non-melanoma skin cancers, based on the same API of NexoBrid and EscharEx products, a concentrate of proteolytic enzymes enriched in bromelain.
Informações de Mediwound Ltd
Código da empresaMDWD
Nome da EmpresaMediwound Ltd
Data de listagemMar 20, 2014
CEOGonen (Ofer)
Número de funcionários111
Tipo de títulosOrdinary Share
Fim do ano fiscalMar 20
Endereço42 Hayarkon Street
CidadeYAVNE
Bolsa de valoresNASDAQ OMX - NASDAQ BASIC
PaísIsrael
Código postal8122745
Telefone972779714100
Sitehttps://www.mediwound.com/
Código da empresaMDWD
Data de listagemMar 20, 2014
CEOGonen (Ofer)
Executivos da empresa Mediwound Ltd
Nome
Nome/Posição
Posição
Ações detidas
Variação
Mr. Ofer Gonen
Mr. Ofer Gonen
Chief Executive Officer, Director
Chief Executive Officer, Director
275.42K
+33.88%
Dr. Vickie R. Driver, M.D.
Dr. Vickie R. Driver, M.D.
Independent Director
Independent Director
--
--
Mr. Stephen T. Wills, CPA
Mr. Stephen T. Wills, CPA
Independent Director
Independent Director
--
--
Dr. Ety Klinger, Ph.D.
Dr. Ety Klinger, Ph.D.
Chief Research and Development Officer
Chief Research and Development Officer
--
--
Mr. Yaron Meyer
Mr. Yaron Meyer
Executive Vice President, General Counsel, Corporate Secretary
Executive Vice President, General Counsel, Corporate Secretary
--
--
Mr. David Fox
Mr. David Fox
Independent Director
Independent Director
--
--
Mr. Jeremy Feffer
Mr. Jeremy Feffer
Managing Director
Managing Director
--
--
Mr. Shmuel (Milky) Rubinstein
Mr. Shmuel (Milky) Rubinstein
Independent Director
Independent Director
--
--
Dr. Shmulik Hess
Dr. Shmulik Hess
Chief Operating Officer, Chief Commercial Officer
Chief Operating Officer, Chief Commercial Officer
--
--
Ms. Hani Luxenburg
Ms. Hani Luxenburg
Chief Financial Officer
Chief Financial Officer
--
--
Ver Mais
Nome
Nome/Posição
Posição
Ações detidas
Variação
Mr. Ofer Gonen
Mr. Ofer Gonen
Chief Executive Officer, Director
Chief Executive Officer, Director
275.42K
+33.88%
Dr. Vickie R. Driver, M.D.
Dr. Vickie R. Driver, M.D.
Independent Director
Independent Director
--
--
Mr. Stephen T. Wills, CPA
Mr. Stephen T. Wills, CPA
Independent Director
Independent Director
--
--
Dr. Ety Klinger, Ph.D.
Dr. Ety Klinger, Ph.D.
Chief Research and Development Officer
Chief Research and Development Officer
--
--
Mr. Yaron Meyer
Mr. Yaron Meyer
Executive Vice President, General Counsel, Corporate Secretary
Executive Vice President, General Counsel, Corporate Secretary
--
--
Mr. David Fox
Mr. David Fox
Independent Director
Independent Director
--
--
Perguntas frequentes
Quem são os cinco principais acionistas de Mediwound Ltd?
Os cinco principais acionistas de Mediwound Ltd são: Mr. Ofer Gonen
Quantas instituições possuem ações da Mediwound Ltd (MDWD)?
Em 2026Q1, 165 instituições possuíam ações da Mediwound Ltd, com valor de mercado aproximado de 7.42M, representando 57.77% do total de ações. Em comparação com 2025Q4, a participação institucional aumentou em 298423.00.